Retrospective longitudinal data (2013–2024) from six immunotherapy-naive MuSK-MG patients yielded 103 observations linking MuSK antibody levels to MG-ADL using generalized linear mixed-effects ...
Efgartigimod alfa–hyaluronidase significantly improves ocular symptoms in adults with ocular myasthenia gravis, according to phase 3 trial data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results